Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Capranico

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drug Design|November 1, 1990
DNA topoisomerase II as the primary target of anti-tumor anthracyclinesF Zunino, G Capranico
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DNA topoisomerase-trapping antitumour drugsG Capranico, F Zunino
Biochimica Et Biophysica Acta|September 28, 1998
DNA sequence selectivity of topoisomerases and topoisomerase poisonsG Capranico, M Binaschi
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
DNA topoisomerase II poisons and inhibitorsG Capranico, G Giaccone, M D'Incalci
Current Pharmaceutical Design|March 6, 1999
Drugs acting on DNA topoisomerases: recent advances and future perspectivesB Gatto, G Capranico, M Palumbo
Chemico-Biological Interactions|January 1, 1989
Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cellsG Capranico, S Tinelli, F Zunino
Nucleic Acids Research|June 25, 1994
Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavageM Bigioni, F Zunino, G Capranico
International Journal of Cancer|February 15, 1986
Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cellsG Capranico, T Dasdia, F Zunino
Stem Cells (Dayton, Ohio)|July 1, 1995
Mechanism of action of DNA topoisomerase inhibitorsM Binaschi, F Zunino, G Capranico
Cancer Research|January 15, 1995
Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moietyG Capranico, E Butelli, F Zunino
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drug Design|November 1, 1990
DNA topoisomerase II as the primary target of anti-tumor anthracyclinesF Zunino, G Capranico
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DNA topoisomerase-trapping antitumour drugsG Capranico, F Zunino
Biochimica Et Biophysica Acta|September 28, 1998
DNA sequence selectivity of topoisomerases and topoisomerase poisonsG Capranico, M Binaschi
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
DNA topoisomerase II poisons and inhibitorsG Capranico, G Giaccone, M D'Incalci
Current Pharmaceutical Design|March 6, 1999
Drugs acting on DNA topoisomerases: recent advances and future perspectivesB Gatto, G Capranico, M Palumbo
Chemico-Biological Interactions|January 1, 1989
Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cellsG Capranico, S Tinelli, F Zunino
Nucleic Acids Research|June 25, 1994
Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavageM Bigioni, F Zunino, G Capranico
International Journal of Cancer|February 15, 1986
Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cellsG Capranico, T Dasdia, F Zunino
Stem Cells (Dayton, Ohio)|July 1, 1995
Mechanism of action of DNA topoisomerase inhibitorsM Binaschi, F Zunino, G Capranico
Cancer Research|January 15, 1995
Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moietyG Capranico, E Butelli, F Zunino
Pageof 9